Full name
WOERWAG PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1 | 1,4 | 1,6 | 11,8 |
EBITDA | 0,5 | 0,9 | 1 | 7,7 |
Short time liabilities | 11,1 | 8,6 | 10,5 | 23,2 |
Equity capital | 3,6 | 3,9 | 4 | 2 |
Operating profit (EBIT) | 1,1 | 1,4 | 1,6 | 11,4 |
Assets | 17,4 | 15,4 | 17,7 | 15,2 |
Net profit (loss) | 0,7 | 1,1 | 1,1 | 7,4 |
Cash | 5 | 1,6 | 1,5 | -8,5 |
Net income from sale | 43,4 | 49,1 | 53,2 | 8,3 |
Liabilities and provisions for liabilities | 13,9 | 11,5 | 13,8 | 19,7 |
Working assets | 15,9 | 14 | 15,2 | 8,8 |
Depreciation | -0,5 | -0,5 | -0,6 | -18 |
% | % | % | p.p. | |
Profitability of capital | 20,9 | 27,3 | 28,7 | 1,4 |
Equity capital to total assets | 20,4 | 25,2 | 22,3 | -2,9 |
Gross profit margin | 2,4 | 2,9 | 3 | 0,1 |
EBITDA Margin | 1,3 | 1,9 | 1,9 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 93 | 64 | 72 | 8 |
Current financial liquidity indicator | 1.2931910753250122 | 1.4096825122833252 | 1.2531006336212158 | -0,1 |
Net dept to EBITDA | -9.175675392150879 | -1.7254548072814941 | -1.4648215770721436 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane